Financial advisory firm Perella Weinberg Partners (NASDAQ:PWP) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 40.8% year on year to $164.6 million. Its non-GAAP profit of $0.13 per share was 10.3% below analysts’ consensus estimates. Is now the time to buy PWP? Find out in our full research report (it’s free for active Edge members). Perella Weinberg (PWP) Q3 CY2025 Highlights: Revenue: $164.6 million vs analyst estimates of $179.8 million (40.8% year-on-year decline, 8 ...

Core Insights - Lazard Ltd is set to release its quarterly earnings on October 23, 2025, with an estimated EPS of $0.44 and revenue of $726.25 million, reflecting a year-over-year EPS increase of 7.9% and revenue growth of 8% [1][5] Earnings Estimates - Analysts have revised the consensus EPS estimate downwards by 1.8% over the past 30 days, which may affect investor sentiment [1][5] Market Reaction - The market's response to earnings estimate revisions is significant; if Lazard's actual earnings exceed expectations, the stock may experience an upward trend, while disappointing earnings could lead to a decline [2] Financial Metrics - Lazard's financial metrics include a price-to-earnings (P/E) ratio of 15.67, a price-to-sales ratio of 1.52, and an enterprise value to sales ratio of 1.37, indicating how the market values its earnings and sales [3] Financial Health - The company has a debt-to-equity ratio of 0.70 and a current ratio of 1.89, suggesting a balanced approach to financing and the ability to cover short-term liabilities with short-term assets [4]